phase readout
saveNCT07630948: Adherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast Cancer
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Institute of Oncology Ljubljana. Phase: PHASE4. Conditions: Breast Cancer, Adherence, Medication
view source ↗
comments(0)
5-min edit window · permanent after that